When I sat down to record this episode of the GLP-1 Collective Podcast, I knew we were in for something special. Dr. Craig Primack, MD, FACP, FAAP, MFOMA, is a leader in obesity medicine, and honestly, he has so many accomplishments that I had to list them in bullet points.

I’m sure I’m still missing a few, but here’s just a glimpse:

Co-founder of Scottsdale Weight Loss Center in Arizona, a multi-location practice serving thousands.
Served on the board of the Obesity Medicine Association from 2010 through 2024.
President of the OMA from 2019 to 2021.
Frequent media guest and national speaker on obesity care.
Co-author of Chasing Diets and widely published in the field.

In addition to his own practice, Dr. Primack works as the Head of Weight Loss at Hims & Hers to help expand access to comprehensive care for those who might not otherwise be able to access it.

White Paper: The Key Takeaways

The main reason Dr. Primack joined me was to share data from a new white paper from his work with Hims & Hers. This first-of-its-kind analysis gives us a real look at how a more personalized approach to care through digital health is changing obesity medicine and what it means for patients right now.

Full disclosure: I’ve never been a Hims & Hers patient, I’m not an affiliate, and I wasn’t paid to share this information or conduct this interview. But without telehealth, I know I’d still be stuck in the exhausting cycle of ‘eat less, move more,’ so I’m forever grateful for telehealth as a whole and glad I had the chance to learn about these findings and share them.

Here are some of the key findings:

Telehealth Impact: Patients accessing personalized GLP-1 treatment plans through Hims & Hers lost an average of 20 pounds, or about 10 percent of their body weight, in six months. That is medically significant weight loss with proven metabolic benefits.
Access Improvement: Instead of waiting months to see one of the fewer than 10,000 obesity specialists in the U.S., patients were able to start treatment in a matter of days.
Comprehensive Care: The Hims & Hers approach is not just about prescribing a GLP-1. Patients receive nutrition tools, movement guidance, education, and 24/7 provider messaging, all of which contributed to a dropout rate of just 25 percent at six months. In contrast, dropout rates for
commercially available GLP-1s can hover around 80% at six
months.

In a nutshell, this white paper analysis shows that digital health isn’t just convenient. It’s delivering real outcomes, keeping people on treatment, and reshaping how we think about obesity care.

Hims & Hers Details

As a GLP-1 freelance writer, I often review telehealth companies. This is my personal observation, not an endorsement. I’m not affiliated with Hims & Hers, and this isn’t a paid review. I’m not breaking down too many details here, since this isn’t a paid telehealth review and that level of depth belongs in my freelance work but I will share some of the highlights that we covered during the interview for anyone interested in learning more.

Here are the details:

Pricing: I found Hims & Hers pricing to be very competitive compared to other options.
24/7 Messaging: patients have continuous access to licensed providers through the app. This means you can get guidance on side effects, dosage, or general concerns from a legitimate provider, without waiting for a call back from your doctor’s office.
Comprehensive Resources: an app that includes protein trackers, recipes, behavioral education, and lifestyle coaching.
Personalized Dosing: Hims & Hers prioritizes safety by providing access to personalized dosing when clinically necessary that’s tailored to each individual’s needs and goals. This can include starting patients on lower, slower titration schedules to reduce side effects. This is also an approach you can discuss with your own provider if side effects become difficult to manage.
Cold Chain Shipping: medications are shipped securely, with climate conditions in mind, at no extra cost.
Certificates of Analysis: every batch comes with a COA that patients can look up themselves, an impressive transparency step I wish we saw everywhere.

These are the key details shared during the interview. For more information, you can check out their websites directly at hims.com or forhers.com.

My Closing Thoughts

As someone who has dedicated my life to making these medications more affordable, equitable, and accessible for everyone who needs them, I deeply respect his impact.

It’s clear that Dr. Primack has heart in everything he does.

He’s proof that obesity medicine can and should be centered on compassion, access, and patient centered care.

That is the future I’m fighting for.

Now — I am off to Audible 📖 to buy Chasing Diets and taking up golfing. 🏌️‍♂️⛳

`Disclaimer: The content of this post is for informational and educational purposes only. It is not medical advice and should not be relied on as a substitute for professional medical care. Always speak directly with your physician or another qualified health provider regarding any questions you may have about a medical condition, treatment, or medication. Never disregard professional medical advice or delay in seeking it because of something you have read or heard here.`

`I am sharing my personal opinions and experiences. These views are my own and do not necessarily represent the views of my nonprofit, the GLP-1 Collective, its board members, affiliates, or any other organization I am associated with.`

I did not receive compensation from Dr. Craig Primack, Scottsdale Weight Loss Center, Hims & Hers, or any other company or organization mentioned in this post. This content is not sponsored. Some links may be affiliate links, which means I may earn a small commission if you purchase through them, at no additional cost to you. Any mention of pricing, services, or treatment options is provided for transparency and informational purposes only, and I make no guarantee that such information will remain accurate over time.

`Nothing in this post creates a doctor–patient relationship, business relationship, or legal relationship of any kind. Readers assume full responsibility for their own healthcare decisions and actions.`

The Future of Weight Loss with GLP-1